financetom
Business
financetom
/
Business
/
Johnson & Johnson's Janssen Unit Ordered to Pay US About $1.64 Billion in HIV Drug Marketing Case
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Johnson & Johnson's Janssen Unit Ordered to Pay US About $1.64 Billion in HIV Drug Marketing Case
Mar 28, 2025 11:29 AM

02:02 PM EDT, 03/28/2025 (MT Newswires) -- A federal district court judge in New Jersey ordered Johnson & Johnson's ( JNJ ) Janssen Products unit on Friday to pay the US government $1.64 billion in damages and civil penalties after a jury found the unit liable for "unlawfully promoting" two HIV/AIDS drugs last year.

Johnson & Johnson ( JNJ ) did not immediately reply to a request for comment from MT Newswires.

Price: 164.34, Change: +1.21, Percent Change: +0.74

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved